Has Christine Ying received payments from drug or device companies?

Yes. Drug and device makers reported $6,494 in general payments to Christine Ying across 302 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christine Ying did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christine Ying come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christine Ying

Physician Assistant · Flemington, NJNPI 1881091460

Payments from drug & device makers

$6,494in general payments, 2019–2025

Across 302 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$725
EMD Serono, Inc.$589
Daiichi Sankyo Inc.$515
Novartis$464
AbbVie$325
E.r. Squibb & Sons, L.L.C.$215
plus $3K from 54 others

What the payments were for

Food & beverage$6,28997%
Education$2053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	42	$725
EMD Serono, Inc.	3	$589
Daiichi Sankyo Inc.	18	$515
Novartis	27	$464
AbbVie	16	$325
E.r. Squibb & Sons, L.L.C.	6	$215
Eisai Inc.	12	$199
Celltrion USA Inc.	2	$169
Gilead(2 entities)	5	$162
GSK	9	$160
AstraZeneca(2 entities)	9	$153
Regeneron Healthcare Solutions, Inc.	6	$147
Bayer	8	$145
Pfizer	6	$138
Takeda Pharmaceuticals U.S.A., Inc.	7	$132
Lilly USA, LLC	7	$132
Incyte Corporation	8	$121
Sobi, Inc	6	$117
Taiho Oncology, Inc.	6	$109
Ipsen Biopharmaceuticals, Inc	5	$87
Dendreon Pharmaceuticals LLC	4	$78
Seagen Inc.	4	$73
ADC Therapeutics America, Inc.	3	$68
Sanofi	3	$61
Beone Medicines USA, Inc.	3	$53
Rigel Pharmaceuticals, Inc.	2	$53
Genentech USA, Inc.	3	$52
Stemline Therapeutics Inc.	3	$52
Karyopharm Therapeutics Inc.	3	$50
Kyowa Kirin, Inc.	3	$50
Morphosys, US Inc.	3	$47
Bristol Myers Squibb	3	$47
Sun Pharmaceutical Industries Inc.	2	$45
Boehringer Ingelheim	3	$43
Servier Pharmaceuticals LLC	2	$40
Coherus Oncology, Inc.	1	$40
Acrotech Biopharma Inc.	1	$39
Beigene USA, Inc.	2	$39
Adaptive Biotechnologies Corporation	2	$39
Novocure Inc.	2	$35
Iovance Biotherapeutics, Inc.	2	$34
Springworks Therapeutics, Inc.	2	$34
Mirati Therapeutics, Inc.	2	$32
Astellas Pharma US Inc	2	$32
AVEO Pharmaceuticals, Inc.	2	$32
Apellis Pharmaceuticals, Inc.	2	$31
Pharmacyclics LLC, An Abbvie Company	2	$31
Octapharma USA, Inc.	2	$30
Heron Therapeutics, Inc.	1	$24
Tempus AI, Inc	1	$24
Agios Pharmaceuticals, Inc.	1	$21
Legend Biotech USA Inc.	1	$19
Azurity Pharmaceuticals, Inc.	1	$19
Invivyd Inc	1	$19
Fennec Pharmaceuticals, Inc.	1	$19
Biocon Biologics Inc	1	$18
Genmab U.S., Inc.	1	$17
Geron Corporation	1	$17
Syndax Pharmaceuticals, Inc.	1	$17
Amgen	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,494 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CreonLipase/Protease/Amylase	14	$5,470
Oxycodone Hcl	12	$316
Gabapentin	11	$189
Prochlorperazine Maleate	12	$126
Ondansetron Hcl	12	$102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieCreon	$325	$5,47014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Flemington

Alexa HetzelEast Windsor$750K
Nicole Schmid DavisHamilton$148K
Todd NewmanHoboken$73K
Patrick McGinnShrewsbury$72K
Tatiana Dell'aquilaNutley$43K
Nicole ColucciRiverdale$36K
Salvatore SciurbaMiddletown$25K
Jacqueline CristiniEdison$22K
Mark MazakLakewood$21K
Andrea BarkerPrinceton$21K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →